Concepedia

Alison Donald

AD

Statistics

Publications

11

Citations

341

H-Index

11

Active since

2008

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (United States)

American College of Chest Physicians

University of Leicester

Alison Donald is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and asthma.

Top concepts

Publications per year

2008–2020

11

Publications

11

Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies

Thomas M. Siler, Edward Kerwin, Ana R. Sousa et al. · Respiratory Medicine · 2015 · 74 citations · Full text

Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials

François Maltais, Sally Singh, Alison Donald et al. · Therapeutic Advances in Respiratory Disease · 2014 · 70 citations · Full text

CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial

Aili L. Lazaar, Bruce E. Miller, Alison Donald et al. · Respiratory Research · 2020 · 67 citations · Full text

An encouraging assessment of methods to inform priorities for updating systematic reviews

Alex J. Sutton, Sarah Donegan, Yemisi Takwoingi et al. · Journal of Clinical Epidemiology · 2008 · 28 citations

, , +10

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 µg on health-related quality of life in patients with COPD

Thomas M. Siler, Alison Donald, Dianne M. O’Dell et al. · International Journal of COPD · 2016 · 28 citations · Full text

1–5 of 11